MetLife, Inc. (MET)

Total return at 5 years: 9.3%/year = 6.8% appreciation + 2.5% dividend. The target price ($134) is ex-dividend; the $14 in dividends collected over 5 years are added separately.

By both methods, the value today (DCF $277 · Multiples $120) exceeds the market price ($96).

Today — fairly valued: at $96 trades ~19.4% below its value discounted to today (~$120); the discount is positive but does not reach the margin of safety we require (≥38%).

At 5 years — En valor: the target price ($134) plus dividends yield between the 4% floor and the 10% average return — a reasonable return, though without the margin of a great investment.

The bridge: the return at 5 years exceeds the risk-free rate (4.5%) — but the discount does not reach the required margin of safety (≥38%). To require a 15% annual return, it would need to be bought at ~$76.

Educational / informational. Does not constitute investment advice.

The inverse approach: instead of projecting growth to obtain the value, the market price ($96) is taken as given and it solves for what annual owner-earnings growth would need to hold for 5 years for the present value —at the method's rate (4.5%, no-growth terminal)— to equal that price. It is the disconfirmation test: the expectations the price already pays for, contrasted against the method's projection.

The market discounts less growth (-16.9%/year) than we project (5.0%/year) → if the base case holds, there is margin: perception is more pessimistic than the estimated reality.

That growth implies ~$2.5 bn of owner earnings in year 5 (vs ~$8.2 bn of our base case). It recalculates if the DCF assumptions are edited.

A bank is valued on equity (P/E × common earnings + price/tangible book), not EV: deposits and debt are funding. It returns capital via dividend + buyback —the buyback reduces the share count, so earnings per share grow faster than aggregate earnings—. Total return adds the dividend collected along the way. In edit mode, the metric, shares, dividend, and exit multiple can be adjusted.

A life and retirement insurer is valued on equity (P/E on adjusted earnings + P/book value excluding AOCI, with adjusted ROE as the profitability measure), not on EV: the float — invested general account reserves, $483bn — is self-funding, not capital structure. GAAP earnings swing sharply due to asymmetric, non-economic derivative hedge accounting and the remeasurement of market risk benefits (they collapsed to $1.6bn in 2023, a year of heavy derivative losses, versus $3.4bn in 2025), so the valuation metric is adjusted earnings available to common shareholders, which MetLife itself excludes those items from: $6.4bn TTM (four quarters through Jun-2026), in line with the company's 2026 target. Rolling grid: the base year is the TTM. Base: adjusted earnings grow ~5.5%/year in year 1 (consistent with the double-digit adjusted earnings-per-share growth target, once the buyback effect is backed out) decelerating smoothly to ~4.3%/year by year 5; the buyback reduces share count ~4.3%/year (the pace revealed over the last twelve months, $1.7bn repurchased so far in 2026); book value excluding AOCI compounds modestly (~3%/year, because the buyback executes above book value — 1.67× today — which dilutes per-share compounding even while being accretive to earnings per share); exit multiple 8.5× (within the [7,11] band of the life-and-retirement archetype, slightly below today's ~9.9×) → target price ~$134. The dividend ($2.372/share, +5%/year) is added to the return.

Today's multiple compresses on its own going forward as the metric per share grows (accelerated by the buyback, which reduces the share count). The exit multiple at 3 years is higher than the terminal at 5 years —at 3 years there is more growth still ahead—. Total return adds the dividend collected; the required return is applied to the base scenario.

They are valued separately, with their own rationale, and are not incorporated into the base or the verdict (they are excess return). When assigning them value — in Editmode —, the total with optionalities updates live, without moving the base.

The verdict, the base CAGR, and the margin of safety are always calculated on the base; optionalities do not alter them (with optionalities at $0 they do not move).

Each card fixes a required annual return and answers: if the business is worth $134 in 5 years, what is the maximum that can be paid today to obtain that return? Since it now trades at $96, the margin of safety is how much cheaper the market is than that maximum. The three thresholds: 4% covers inflation (the floor), 10% is the long-term average return, and 15% is the level of a great investment.

With a target price of $134 in 5 years plus $14 of dividends collected (the dividend adds to the return, not to the price) and a required return of 4.5% annually, the maximum to pay today is $120. Against the current market price ($96), the margin of safety is 19.4% (trades below the maximum → there is margin) and the total return at that price would be 9.3% annually.

• Multiple vs the band. ~10× adjusted earnings, within the [7,11] band of the life-and-retirement archetype — no marked discount or premium versus the center of the band.
• Near highs. Trades within 4% of its 52-week high — there is no evident panic or discount signal in the price.
• Margin of safety. 5-year base ~$134 vs price ~$96 → total return +9%/year (modest compounding of adjusted earnings + growing dividend). No clear margin of safety at the current price.

• ROE vs the 10% bar. Adjusted ROE 17.0% (2Q'26) — above the 10% bar, at the top of the 2026 target (15-17%). ROE on reported GAAP earnings is lower and more volatile due to derivative accounting.
• Earnings quality. GAAP earnings are depressed and erratic due to asymmetric, non-economic derivative hedge accounting and the remeasurement of market risk benefits (FY23: $1.6bn versus that year's much higher adjusted earnings). The adjusted earnings MetLife itself guides to is the correct metric for judging value generation.
• The float. $483bn of invested general account reserves, generating ~$22bn/year of adjusted net investment income — self-funding that yields more with high rates.

Annual levels from the official filing (10-K); the % over each bar is the year-over-year (YoY) growth vs the prior year.

The engine of a life and retirement insurer is underwriting (mortality and morbidity margin in Group Benefits) plus the investment spread on the general account float ($483bn), which yields more with high rates. The profitability metric is adjusted ROE, excluding the non-economic volatility of derivative accounting (17.0% in the latest quarter, at the top of the 2026 target of 15-17%). Book value per share excluding AOCI is the correct compounding metric (reported GAAP moves with the level of rates, not with the business). MetLife returns capital via a dividend (growing ~5%/year) and sustained buybacks (~4.3%/year net share count reduction over the last twelve months).

The % are the annual (year-over-year) growth: each year —historical and projected— vs the prior one; the TTM (trailing 12m) vs the TTM of a year ago, to avoid overlapping windows. The historicals are exact figures from the official filings; the projected years come from the year-by-year model (the intermediate years without their own series are interpolated between the anchors). The projected columns (+1y…+5y) are 12-month windows counted from the TTM close (30-jun-2026): the projection starts from the most recently reported data, not the fiscal year. The projected base is realistic and unbiased — the risk discount is applied at the end, via the required return. The rationale for each metric is in the (i).

• Real, not nominal. Growth (premiums and fees ~5%/year consolidated, with Group Benefits and Asia above) is real: new business and renewal volume, not monetary inflation.
• Growth engine. Premium volume in Group Benefits, pension risk transfers in RIS (irregular quarter to quarter), growth in Asia and Latin America, and float investment income rising with rates. Modest (~5%/year consolidated), diversified by geography and line.
• Sensitivity to the rate cycle. Growth in the annuity and pension business (RIS) depends in part on the level of rates — higher rates make pension risk transfers more attractive to plan-sponsoring employers, but also compress the margin on guarantees already written at lower rates.

• Relevant in 10 years (recurrence). Life and group benefits insurance is essential and recurring (policies renew, employer plans are re-bid but do not disappear). MetLife will still be used in 10 years; recurrence is high.
• Pricing power. Limited and competitive: in Group Benefits, pricing is set through an annual bid with the employer; in RIS, a pension transfer is quoted against several insurers. The power lies in underwriting discipline, not in freely setting prices.
• Moat and its direction. Wide moat (scale, brand, regulatory barriers, distribution), stable direction — no evidence of a widening unit-economics gap.
• Interest rate sensitivity. The central disconfirmer: the profitability of a life and retirement balance sheet depends on the spread between the portfolio yield and the rate credited to policyholders. Both rising and falling rates pressure profitability in different ways.

• ✕Book value compounding+3%/yr · $58/share ex-AOCI · core ROE 17%
• ✓Float return (investment income)$22.1 bn on $482.6 bn of float
• !Statutory solvency (risk-based capital)3.70× of the authorized minimum
• ✕Investment spread0.97 pp

A traffic-light interpreted by the method (not generic): float (negative WC) adds up, capex is judged by incremental ROIC (malinvestment test), and a lender is not subjected to corporate solvency. The (i) shows the derivation of each number.

• Regulatory capital. Combined RBC (NAIC basis) above 370% at year-end 2025, well above regulatory minimums, with a slight deterioration from >380% in 2024.
• Asset leverage. 26× (assets of $759bn against equity of $27bn) — structural to a life and retirement balance sheet, backed by long-term actuarial reserves rather than short-term debt, but it means a small credit move shifts the entire equity base.
• Investment spread. The general account's annualized spread in RIS runs around ~1.0% — positive but thin, sensitive in both directions to the level of rates.

Who owns the shares — the alignment and whether there is a controlling shareholder.

• Skin in the game. The available proxy does not break out director and executive ownership as a group. There is no founder or active controlling shareholder; ownership is spread among large institutional managers and the remaining trust from the 2000 demutualization.
• Capital allocation. Reinvests at the adjusted ROE (17.0%, above the 10% bar) and returns the rest via a growing dividend (~5%/year) + sustained buybacks (~$1.7bn in 2026), within an explicit target of free cash flow to adjusted earnings of 65-75%.
• Execution / integrity. Adjusted ROE held within the 15-17% target range over the last five reported quarters, including one quarter with a material adverse reserve review (3Q'25) — evidence of operational resilience, though without an extraordinary track record that distinguishes MetLife from its direct peers.

• There is no evident missing-buyers or motivated-sellers catalyst in the filing: MetLife trades near 52-week highs (4% below the high) and with broad analyst coverage.
• Reported GAAP earnings are deceptively low in specific years (FY23: $1.6bn) due to asymmetric derivative hedge accounting — a reader looking only at historical GAAP could underestimate true earning power, which adjusted earnings ($6.4bn TTM) reflects better.
• The multiple (~9.9× adjusted earnings today) sits within the typical band for a balance-sheet life and retirement insurer, with no marked discount or premium versus peers like Prudential or Voya.

MetLife is neither clearly cheap nor expensive: it trades near highs at a multiple within the typical range for its category, on adjusted earnings that already exclude the non-economic volatility of derivative accounting. The missing-buyers/motivated-sellers read does not apply strongly: there is no recent spin-off, exchange jump, one-off impairment, or absent analyst coverage. The projected total return combines modest compounding of adjusted earnings, sustained buybacks, and a growing dividend — consistent with a quality insurer at a reasonable price, not a deep-discount opportunity.

The annual return (CAGR at 5 years) in each scenario, with the total period return below — the margin of safety made visual: upside range wide, downside range narrow.

Even in the bear scenario, the return holds at +1%/year (+7% total): the margin of safety protects the downside. The bull (+16%/year, +107% total) exceeds it comfortably — a favorable asymmetry, with a narrow downside range and a wide upside range.

• Interest rate and investment spread. The central disconfirmer: both rising and falling rates hurt the profitability of a life and retirement balance sheet with long-term liabilities and contractual guarantees.
• Actuarial assumption review. An adverse review (like the one in 3Q'25) can move reserves materially in a single quarter — a structural risk for any long-term life insurer.
• Regulatory. An extensive and changing framework (capital, principles-based reserving starting in 2026, possible systemic designation) can limit growth or restrict dividends from subsidiaries.
• Valuation near highs. Trades within 4% of its 52-week high, within the band for its category — little room for re-rating from the current level.

Each thinker's analytical framework applied to our data.

• Buffett / Graham Quality + margin of safety

  A wide moat and ROE 17% above the 10% bar, but the margin is limited (+19%) → excellent business at a fair price.

• Peter Lynch Growth at a reasonable price (GARP)

  A stalwart growing 5% at a PEG of 1.9 → reasonable for its growth.

• Joel Greenblatt Cheap and high-return (Magic Formula)

  Not applicable — the Magic Formula excludes financials and regulated businesses (EBIT/EV does not capture the operating leverage).

• Howard Marks Perception vs reality + cycle

  The price discounts -17% vs our 5%: perception is more pessimistic than reality, with an identified source of the discount.

• Seth Klarman Capital protection (bear scenario)

  Bear-scenario floor -2%/yr, bull-scenario ceiling +13%/yr over 5y → capital protected, asymmetry in your favor.

• Pat Dorsey Moat strength (Five Rules)

  A wide moat, stable; sources: intangibles, efficient scale, cost advantage, switching costs → passes the Five Rules.

• Aswath Damodaran Expectations implied by the price

  Justifying the price requires discounting -17%, within what we project (5%) — the story squares with the numbers.